Studies on brain volume, Alzheimer-related proteins and cytokines in mice with chronic overexpression of IL-1 receptor antagonist

Journal of Cellular and Molecular Medicine

Volumn 11, Issue 4, 2007, Pages 810-825

  Oprica, M ^a,c   Hjorth, E ^a   Spulber, S ^a   Popescu, B O ^b   Ankarcrona, M ^a   Winblad, B ^a   Schultzberg, M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amyloid precursor protein; Brain volume; Interleukin; Mouse; Presenilin; Transgenic

Indexed keywords

ANIMALIA; MUS; MUS MUSCULUS;

EID: 34548191207     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2007.00074.x     Document Type: Article

References (56)

1. Rothwell NJ, Luheshi GN. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 2000 23 : 618 25.
2. Minami M, Kuraishi Y, Yabuuchi K, Yamazaki A, Satoh M. Induction of interleukin-1β mRNA in rat brain after transient forebrain ischemia. J Neurochem. 1992 58 : 390 2.
3. Stroemer RP, Rothwell NJ. Exacerbation of ischemic brain damage by localized striatal injection of interleukin- 1β in the rat. J Cereb Blood Flow Metab. 1998 18 : 833 9.
4. Blume AJ, Vitek MP. Focusing on IL-1-promotion of β-amyloid precursor protein synthesis as an early event in Alzheimer's disease. Neurobiol Aging. 1989 10 : 406 8.
5. Giulian D, Young DG, Woodward J, Brown DC, Lachman LB. Interleukin-1 is an astroglial growth factor in the developing brain. J Neurosci. 1988 8 : 709 14.
6. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996 87 : 2095 147.
7. Avital A, Goshen I, Kamsler A, Segal M, Iverfeldt K, Richter-Levin G, Yirmiya R. Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity. Hippocampus. 2003 13 : 826 34.
8. Schneider H, Pitossi F, Balschun D, Wagner A, del Rey A, Besedovsky HO. A neuromodulatory role of interleukin-1β in the hippocampus. Proc Natl Acad Sci USA. 1998 95 : 7778 83.
9. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood. 1991 77 : 1627 52.
10. Eisenberg SP, Evans RJ, Arend WP, Verderber 0E, Brewer MT, Hannum CH, Thompson RC. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature. 1990 343 : 341 6.
11. Arend WP. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 2002 13 : 323 40.
12. Eriksson C, Winblad B, Schultzberg M. Kainic acid induced expression of interleukin-1 receptor antagonist mRNA in the rat brain. Mol Brain Res. 1998 58 : 195 208.
13. Eriksson C, Van Dam AM, Lucassen PJ, Bol JG, Winblad B, Schultzberg M. Immunohistochemical localization of interleukin-1β, interleukin-1 receptor antagonist and interleukin-1β-converting enzyme/caspase-1 in the rat brain after peripheral administration of kainic acid. Neuroscience. 1999 93 : 915 30.
14. Vezzani A, Moneta D, Richichi C, Aliprandi M, Burrows SJ, Ravizza T, Perego C, De Simoni MG. Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia. 2002 43 : 30 5.
15. Oprica M, Eriksson C, Schultzberg M. Inflammatory mechanisms associated with brain damage induced by kainic acid with special reference to the interleukin-1 system. J Cell Mol Med. 2003 7 : 127 40.
16. Wang X, Barone FC, Aiyar NV, Feuerstein GZ. Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats. Stroke. 1997 28 : 155 61.
17. Hill JK, Gunion-Rinker L, Kulhanek D, Lessov N, Kim S, Clark WM, Dixon MP, Nishi R, Stenzel-Poore MP, Eckenstein FP. Temporal modulation of cytokine expression following focal cerebral ischemia in mice. Brain Res. 1999 820 : 45 54.
18. Relton JK, Martin D, Thompson RC, Russel DA. Peripheral administration of interleukin-1 receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. Exp Neurol. 1996 138 : 206 13.
19. Betz AL, Yang GY, Davidson BL. Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J Cereb Blood Flow Metab. 1995 15 : 547 51.
20. Yang GY, Liu XH, Kadoya C, Zhao YJ, Mao Y, Davidson BL, Betz AL. Attenuation of ischemic inflammatory response in mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist. J Cereb Blood Flow Metab. 1998 18 : 840 7.
21. Loscher CE, Mills KH, Lynch MA. Interleukin-1 receptor antagonist exerts agonist activity in the hippocampus independent of the interleukin-1 type I receptor. J Neuroimmunol. 2003 137 : 117 24.
22. Griffin WS, Mrak RE. Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J Leukoc Biol. 2002 72 : 233 8.
23. Brugg B, Dubreul YL, Huber G, Wollman EE, Delhaye-Bouchaud N, Mariani J. Inflammatory processes induce β-amyloid precursor protein changes in mouse brain. Proc Natl Acad Sci USA. 1995 92 : 3032 5.
24. Buxbaum JD, Oishi M, Chen HI, Pinkas-Kramarski R, Jaffe EA, Gandy SE, Greengard P. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc Natl Acad Sci. 1992 89 : 10075 8.
25. Forloni G, Demicheli F, Giorgi S, Bendotti C, Angeretti N. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Mol Brain Res. 1992 16 : 128 34.
26. Liao YF, Wang BJ, Cheng HT, Kuo LH, Wolfe MS. Tumor necrosis factor-α, interleukin-1β, and interferon- γ stimulate γ-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. J Biol Chem. 2004 279 : 49523 32.
27. Herreman A, Serneels L, Annaert W, Collen D, Schoonjans L, De Strooper B. Total inactivation of γ-secretase activity in presenilin-deficient embryonic stem cells. Nature Cell Biol. 2000 2 : 461 2.
28. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu CE, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu Y-H, Guenette SY, Galas D, Nemens E, Wijsman EM, Bird TD, Schellenberg GD, Tanzi RE. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 1995 269 : 973 7.
29. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, Mar L, Sorbi S, Nacmias B, Piacentini S, Amaducci L, Chumakov I, Coben D, Lannfelt L, Freaser PE, Rommens JM, St George-Hyslop PH. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 1995 376 : 775 8.
30. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Holman K, Tsuda T, Mar L, Foncin J-F, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH. Cloning of a gene gearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995 375 : 754 60.
31. Lundkvist J, Sundgren-Andersson AK, Tingsborg S, Ostlund P, Engfors C, Alheim K, Bartfai T, Iverfeldt K, Schultzberg M. Acute-phase responses in transgenic mice with CNS overexpression of IL-1 receptor antagonist. Am J Physiol. 1999 276 : R644 51.
32. Zhang YH, Lin JX, Vilcek J. Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence. Mol Cell Biol. 1990 10 : 3818 23.
33. Bargetzi MJ, Lantz M, Smith CG, Torti FM, Olsson I, Eisenberg SP, Starnes HF, Jr. Interleukin-1β induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humans. Cancer Res. 1993 53 : 4010 3.
34. Ledesma E, Martinez I, Cordova Y, Rodriguez-Sosa M, Monroy A, Mora L, Soto I, Ramos G, Weiss B, Santiago Osorio E. Interleukin-1β (IL-1β) induces tumor necrosis factor α (TNF-α) expression on mouse myeloid multipotent cell line 32D cl3 and inhibits their proliferation. Cytokine. 2004 26 : 66 72.
35. Vezzani A, Moneta D, Conti M, Richichi C, Ravizza T, De Luigi A, De Simoni MG, Sperk G, Andell-Jonsson S, Lundkvist J, Iverfeldt K, Bartfai T. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci USA. 2000 97 : 11534 9.
36. Tehranian R, Andell-Jonsson S, Beni SM, Yatsiv I, Shohami E, Bartfai T, Lundkvist J, Iverfeldt K. Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist. J Neurotrauma. 2002 19 : 939 51.
37. Oprica M, Van Dam AM, Lundkvist J, Iverfeldt K, Winblad B, Bartfai T, Schultzberg M. Effects of chronic overexpression of interleukin-1 receptor antagonist in a model of permanent focal cerebral ischemia in mouse. Acta Neuropathol. 2004 108 : 69 80.
38. Goshen I, Yirmiya R, Iverfeldt K, Weidenfeld J. The role of endogenous interleukin-1 in stress-induced adrenal activation and adrenalectomy-induced adrenocorticotropic hormone hypersecretion. Endocrinology. 2003 144 : 4453 8.
39. Oprica M, Zhu S, Goiny M, Pham TM, Mohammed AH, Winblad B, Bartfai T, Schultzberg M. Transgenic overexpression of interleukin-1 receptor antagonist in the CNS influences behaviour, serum corticosterone and brain monoamines. Brain Behav Immun. 2005 19 : 223 34.
40. Jelaso AM, Acevedo S, Dang T, Lepere A, Ide CF. Interleukin-1β and its type 1 receptor are expressed in developing neural circuits in the frog, Xenopus laevis. J Comp Neurol. 1998 394 : 242 51.
41. Brenneman DE, Schultzberg M, Bartfai T, Gozes I. Cytokine regulation of neuronal survival. J Neurochem. 1992 58 : 454 60.
42. Jelaso AM, Acevedo S, Dang T, Lepere A, Ide CF. Interleukin-1beta and its type 1 receptor are expressed in developing neural circuits in the frog, Xenopus laevis. J Comp Neurol. 1998 394 : 242 51.
43. Dziegielewska KM, Moller JE, Potter AM, Ek J, Lane MA, Saunders NR. Acute-phase cytokines IL-1β and TNF-α in brain development. Cell Tissue Res. 2000 299 : 335 45.
44. Schottelius AJ, Moldawer LL, Dinarello CA, Asadullah K, Sterry W, Edwards CK, 3rd. Biology of tumor necrosis factor-_α- implications for psoriasis. Exp Dermatol. 2004 13 : 193 222.
45. Barger SW, Harmon AD. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature. 1997 388 : 878 81.
46. Del Bo R, Angeretti N, Lucca E, De Simoni MG, Forloni G. Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures. Neurosci Lett. 1995 188 : 70 4.
47. Lindberg C, Hjorth E, Post C, Winblad B, Schultzberg M. Cytokine production by a human microglial cell line: effects of β-amyloid and α-melanocyte-stimulating hormone. Neurotoxicity Res. 2005 8 : 267 76.
48. Yang Y, Quitschke WW, Brewer GJ. Upregulation of amyloid precursor protein gene promoter in rat primary hippocampal neurons by phorbol ester, IL-1 and retinoic acid, but not by reactive oxygen species. Brain Res Mol Brain Res. 1998 60 : 40 9.
49. Satoh J-I, Kuroda Y. Constitutive and cytokine-regulated expression of presenilin-1 and presenilin-2 genes in human neural cell lines. Neuropathol Appl Neurobiol. 1999 25 : 492 503.
50. Bazan NG, Lukiw WJ. Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1β and amyloid β42 peptide is potentiated by hypoxia in primary human neural cells. J Biol Chem. 2002 277 : 30359 67.
51. Lee J, Chan SL, Mattsson MP. Adverse effects of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain. Neuromolecular Med. 2002 2 : 29 45.
52. Sharman KG, Sharman EH, Yang E, Bondy SC. Dietary melatonin selectively reverses age-related changes in cortical cytokine mRNA levels, and their responses to an inflammatory stimulus. Neurobiol Aging. 2002 23 : 633 8.
53. Nordstedt C, Gandy SE, Alafuzoff I, Caporaso GL, Iverfeldt K, Grebb J, Winblad B, Greengard P. Alzheimer β/A4 amyloid precursor protein in human brain: aging-associated increases in holoprotein and in a proteolytic fragment. Proc Natl Acad Sci. 1991 88 : 8910 4.
54. Kawarabayashi T, Shoji M, Yamaguchi H, Tanaka M, Harigaya Y, Ishiguro K, Hirai S. Amyloid beta protein precursor accumulates in swollen neurites throughout rat brain with aging. Neurosci Lett. 1993 153 : 73 6.
55. Nordstedt C, Gandy SE, Alafuzoff I, Caporaso GL, Iverfeldt K, Grebb JA, Winblad B, Greengard P. Alzheimer beta/A4 amyloid precursor protein in human brain: aging-associated increases in holoprotein and in a proteolytic fragment. Proc Natl Acad Sci USA. 1991 88 : 8910 4.
56. Mouton PR, Long JM, Lei DL, Howard V, Jucker M, Calhoun ME, Ingram DK. Age and gender effects on microglia and astrocyte numbers in brains of mice. Brain Res. 2002 956 : 30 5.